Prothena Corp Public (PRTA) Cash & Current Investments (2012 - 2026)

Prothena Corp Public's (PRTA) quarterly Cash & Current Investments came in at $329.5 million in Q1 2026, down 21.17% year-on-year from $417.9 million in Q1 2025, and up 7.13% quarter-over-quarter from $307.5 million in Q4 2025.

Prothena Corp Public (PRTA) Cash & Current Investments (2012 - 2026) Analysis & Trends

Prothena Corp Public's Cash & Current Investments history runs 15 years deep, the most recent figure standing at $329.5 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 21.17% year-over-year to $329.5 million in Q1 2026; TTM through Mar 2026 was $329.5 million, a 21.17% decrease from a year earlier, with the FY2025 full-year figure at $307.5 million, down 34.76% from the prior year.
  • Cash & Current Investments climbed to $329.5 million in Q1 2026 per PRTA's latest filing, from $307.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $710.4 million in Q4 2022 and bottomed at $307.5 million in Q4 2025.
  • The 5-year median for Cash & Current Investments is $519.3 million (2024), against an average of $515.1 million.
  • Across the five-year window, Cash & Current Investments surged 57.69% in 2022 and plunged 36.29% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $710.4 million in 2022, then decreased by 12.7% to $620.2 million in 2023, then decreased by 23.99% to $471.4 million in 2024, then sank by 34.76% to $307.5 million in 2025, then increased by 7.13% to $329.5 million in 2026.
  • Per Business Quant, the three latest PRTA Cash & Current Investments figures stand at $329.5 million (Q1 2026), $307.5 million (Q4 2025), and $330.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Prothena Corp Public 467.80 Mn 138.33 Mn - 329.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 329.46 Mn
Dec 31, 2025 307.53 Mn
Sep 30, 2025 330.84 Mn
Jun 30, 2025 371.40 Mn
Mar 31, 2025 417.94 Mn
Dec 31, 2024 471.39 Mn
Sep 30, 2024 519.26 Mn
Jun 30, 2024 564.12 Mn
Mar 31, 2024 547.86 Mn
Dec 31, 2023 620.18 Mn
Sep 30, 2023 672.25 Mn
Jun 30, 2023 660.46 Mn
Mar 31, 2023 686.18 Mn
Dec 31, 2022 710.41 Mn
Sep 30, 2022 495.63 Mn
Jun 30, 2022 508.80 Mn
Mar 31, 2022 542.99 Mn
Dec 31, 2021 579.09 Mn
Sep 30, 2021 600.10 Mn
Jun 30, 2021 401.18 Mn